echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Infection > Oseltamivir treats flu, beware of this serious adverse reaction!

    Oseltamivir treats flu, beware of this serious adverse reaction!

    • Last Update: 2021-04-18
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Only for medical professionals to read Reference Case 1 Case Summary The patient, female, 53 years old, was admitted to the hospital due to "numbness and weakness of limbs".

    Symptoms such as numbness of limbs, muscle tremor, and dull face appeared 2 hours ago.

    One day before, she had taken oseltamivir (75 mg bid) to treat acute upper respiratory tract infection.

    After the disease was returned to the hospital, oseltamivir was discontinued, and treatments such as ibuprofen sustained-release capsules (300 mg bid) were given.
    Two days later, the patient's symptoms improved.

    Case 2 Case overview A child, 2 years and 1 month old, came to the outpatient clinic due to abnormal behavior, and developed sleep disorders, loud noises and other symptoms one day ago.

    I took oseltamivir (30mg bid) 2 days ago to treat influenza virus infection.

    Oseltamivir was discontinued after the disease, and children's paracetamol Huangnamin granules (1 bag of tid) were given, bed rest, drink plenty of water, nutrition, and easy-to-digest diet.

    After stopping oseltamivir, the children's mental symptoms disappeared and the flu symptoms eased.

    Case analysis Oseltamivir is a commonly used antiviral drug, but this drug can cause neuropsychiatric symptoms, which mainly refers to the symptoms of nervous system disorders and mental abnormalities after flu patients use oseltamivir.

     According to the App-Medication Query of the Doctor Station, the oseltamivir precautions column mentioned: flu patients (especially children and adolescents) who use this product have had reports of convulsions and delirium.

    The safety and effectiveness of oseltamivir in the treatment of influenza in children under 1 year of age have not been determined.

    Doctor Station App—Screenshot of medication query During the use of the drug, both doctors and patients should be aware of the potential neuropsychiatric adverse reactions, especially when prescribing drugs to children to avoid serious adverse events.

    How to quickly understand adverse drug reactions? How to effectively avoid the occurrence of adverse events? The Doctor Station App provides not only medication precautions but also all aspects of medication knowledge! Download the Doctor Station App on your mobile phone to check medication knowledge anytime, anywhere! Medication query 1.
    Log in to the medical doctor station (if not installed, you can click on the QR code or read the original download) 2.
    Find the "medication" query (free use) 3.
    Quickly look up drug information in the catalog 4.
    Precisely locate keywords Scan the code to download the doctor station App5w+ drugs are free for you to query
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.